• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PRMT5在癌症中的功能及靶向作用。

PRMT5 function and targeting in cancer.

作者信息

Kim Hyungsoo, Ronai Ze'ev A

机构信息

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.

出版信息

Cell Stress. 2020 Jul 13;4(8):199-215. doi: 10.15698/cst2020.08.228.

DOI:10.15698/cst2020.08.228
PMID:32743345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7380451/
Abstract

Protein methyl transferases play critical roles in numerous regulatory pathways that underlie cancer development, progression and therapy-response. Here we discuss the function of PRMT5, a member of the nine-member PRMT family, in controlling oncogenic processes including tumor intrinsic, as well as extrinsic microenvironmental signaling pathways. We discuss PRMT5 effect on histone methylation and methylation of regulatory proteins including those involved in RNA splicing, cell cycle, cell death and metabolic signaling. In all, we highlight the importance of PRMT5 regulation and function in cancer, which provide the foundation for therapeutic modalities targeting PRMT5.

摘要

蛋白质甲基转移酶在众多调控通路中发挥关键作用,这些通路构成了癌症发生、发展及治疗反应的基础。在此,我们讨论PRMT5(PRMT家族九个成员之一)在控制致癌过程中的功能,这些过程包括肿瘤内在以及外在的微环境信号通路。我们探讨PRMT5对组蛋白甲基化以及调控蛋白甲基化的影响,这些调控蛋白包括参与RNA剪接、细胞周期、细胞死亡和代谢信号传导的蛋白。总之,我们强调PRMT5调控和功能在癌症中的重要性,这为靶向PRMT5的治疗方式提供了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698c/7380451/6598d7725be5/ces-04-199-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698c/7380451/dac4ef162b6a/ces-04-199-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698c/7380451/beae0baf038e/ces-04-199-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698c/7380451/6be0b381b698/ces-04-199-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698c/7380451/8973cbb34b7e/ces-04-199-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698c/7380451/6f9873647c13/ces-04-199-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698c/7380451/6598d7725be5/ces-04-199-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698c/7380451/dac4ef162b6a/ces-04-199-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698c/7380451/beae0baf038e/ces-04-199-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698c/7380451/6be0b381b698/ces-04-199-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698c/7380451/8973cbb34b7e/ces-04-199-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698c/7380451/6f9873647c13/ces-04-199-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698c/7380451/6598d7725be5/ces-04-199-g006.jpg

相似文献

1
PRMT5 function and targeting in cancer.PRMT5在癌症中的功能及靶向作用。
Cell Stress. 2020 Jul 13;4(8):199-215. doi: 10.15698/cst2020.08.228.
2
A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.转化生长因子β-蛋白精氨酸甲基转移酶5-甲基磷酸酯酶50轴通过组蛋白H3和H4精氨酸甲基化偶联的转录激活和抑制来调节癌细胞侵袭。
Oncogene. 2017 Jan 19;36(3):373-386. doi: 10.1038/onc.2016.205. Epub 2016 Jun 6.
3
Histone H2A and H4 N-terminal tails are positioned by the MEP50 WD repeat protein for efficient methylation by the PRMT5 arginine methyltransferase.组蛋白H2A和H4的N端尾巴由MEP50 WD重复蛋白定位,以便由PRMT5精氨酸甲基转移酶进行高效甲基化。
J Biol Chem. 2015 Apr 10;290(15):9674-89. doi: 10.1074/jbc.M115.636894. Epub 2015 Feb 24.
4
MEP50/PRMT5 Reduces Gene Expression by Histone Arginine Methylation and this Is Reversed by PKCδ/p38δ Signaling.MEP50/PRMT5 通过组蛋白精氨酸甲基化降低基因表达,而蛋白激酶 Cδ/p38δ 信号传导可逆转这种情况。
J Invest Dermatol. 2016 Jan;136(1):214-224. doi: 10.1038/JID.2015.400.
5
Discovery and Biological Characterization of PRMT5:MEP50 Protein-Protein Interaction Inhibitors.PRMT5:MEP50 蛋白-蛋白相互作用抑制剂的发现与生物学特征分析。
J Med Chem. 2022 Oct 27;65(20):13793-13812. doi: 10.1021/acs.jmedchem.2c01000. Epub 2022 Oct 7.
6
Development of an AlphaLISA high throughput technique to screen for small molecule inhibitors targeting protein arginine methyltransferases.开发一种AlphaLISA高通量技术以筛选靶向蛋白质精氨酸甲基转移酶的小分子抑制剂。
Mol Biosyst. 2017 Nov 21;13(12):2509-2520. doi: 10.1039/c7mb00391a.
7
Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer.蛋白质精氨酸甲基转移酶5(PRMT5)在癌症中的失调。
Oncotarget. 2018 Nov 30;9(94):36705-36718. doi: 10.18632/oncotarget.26404.
8
Productive mRNA Chromatin Escape is Promoted by PRMT5 Methylation of SNRPB.PRMT5介导的SNRPB甲基化促进了有功能的mRNA从染色质中逃逸。
bioRxiv. 2024 Aug 12:2024.08.09.607355. doi: 10.1101/2024.08.09.607355.
9
Protein arginine methyltransferase 5 catalyzes substrate dimethylation in a distributive fashion.蛋白质精氨酸甲基转移酶5以分布的方式催化底物二甲基化。
Biochemistry. 2014 Dec 23;53(50):7884-92. doi: 10.1021/bi501279g. Epub 2014 Dec 8.
10
The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLAR in human lung cancer cells.精氨酸甲基转移酶 PRMT5 和 PRMT1 分别调控人肺癌细胞中抗凋亡蛋白 CFLAR 的降解。
J Exp Clin Cancer Res. 2019 Feb 8;38(1):64. doi: 10.1186/s13046-019-1064-8.

引用本文的文献

1
Therapeutic Potential of Isoxazole-(Iso)oxazole Hybrids: Three Decades of Research.异恶唑-(异)恶唑杂化物的治疗潜力:三十年研究历程
Int J Mol Sci. 2025 Jul 23;26(15):7082. doi: 10.3390/ijms26157082.
2
Therapeutic targeting of protein arginine methyltransferases reduces breast cancer progression by disrupting angiogenic pathways.对蛋白质精氨酸甲基转移酶的治疗性靶向通过破坏血管生成途径来降低乳腺癌进展。
Biochem Biophys Rep. 2025 Jul 31;43:102172. doi: 10.1016/j.bbrep.2025.102172. eCollection 2025 Sep.
3
PRMT5 Identified as a Viable Target for Combination Therapy in Preclinical Models of Pancreatic Cancer.

本文引用的文献

1
PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity.PRMT5对cGAS/STING和NLRC5通路的调控决定了黑色素瘤对抗肿瘤免疫的反应。
Sci Transl Med. 2020 Jul 8;12(551). doi: 10.1126/scitranslmed.aaz5683.
2
PRMT5 Is Required for T Cell Survival and Proliferation by Maintaining Cytokine Signaling.PRMT5 通过维持细胞因子信号来维持 T 细胞的存活和增殖。
Front Immunol. 2020 Apr 9;11:621. doi: 10.3389/fimmu.2020.00621. eCollection 2020.
3
Roles and mechanisms of alternative splicing in cancer - implications for care.
PRMT5被确定为胰腺癌临床前模型联合治疗的可行靶点。
Biomolecules. 2025 Jun 30;15(7):948. doi: 10.3390/biom15070948.
4
PRMT5:MEP50 Are Mediators of Treatment-Induced Neuroendocrine Differentiation in Prostate Cancer.PRMT5:MEP50是前列腺癌治疗诱导神经内分泌分化的介质。
Prostate. 2025 Jul 17. doi: 10.1002/pros.70006.
5
Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group.儿童非横纹肌肉瘤软组织肉瘤中进一步研究新型药物的优先级排序:来自儿童肿瘤协作组的报告
Eur J Cancer. 2025 Aug 26;226:115600. doi: 10.1016/j.ejca.2025.115600. Epub 2025 Jul 6.
6
Emerging roles of protein arginine methyltransferase in multiple myeloma.蛋白质精氨酸甲基转移酶在多发性骨髓瘤中的新作用。
Mol Ther Oncol. 2025 May 26;33(2):201003. doi: 10.1016/j.omton.2025.201003. eCollection 2025 Jun 18.
7
Molecular Insights into Pleural Mesothelioma: Unveiling Pathogenic Mechanisms and Therapeutic Opportunities.胸膜间皮瘤的分子见解:揭示致病机制与治疗机遇
Diagnostics (Basel). 2025 May 24;15(11):1323. doi: 10.3390/diagnostics15111323.
8
PRMT5 K240lac confers ferroptosis resistance via ALKBH5/SLC7A11 axis in colorectal cancer.PRMT5 K240lac通过ALKBH5/SLC7A11轴赋予结直肠癌铁死亡抗性。
Oncogene. 2025 May 30. doi: 10.1038/s41388-025-03457-2.
9
PRMT1 promotes immune escape in hepatocellular carcinoma by regulating arginine methylation modification of MYC protein.PRMT1通过调节MYC蛋白的精氨酸甲基化修饰促进肝细胞癌的免疫逃逸。
Epigenetics. 2025 Dec;20(1):2509044. doi: 10.1080/15592294.2025.2509044. Epub 2025 May 22.
10
The evolving landscape of epigenetic target molecules and therapies in myeloid cancers: focus on acute myeloid leukemia and myeloproliferative neoplasms.髓系癌症中表观遗传靶分子与疗法的演变格局:聚焦急性髓系白血病和骨髓增殖性肿瘤
Leukemia. 2025 May 15. doi: 10.1038/s41375-025-02639-x.
剪接在癌症中的作用和机制——对治疗的影响。
Nat Rev Clin Oncol. 2020 Aug;17(8):457-474. doi: 10.1038/s41571-020-0350-x. Epub 2020 Apr 17.
4
A Binary Arginine Methylation Switch on Histone H3 Arginine 2 Regulates Its Interaction with WDR5.组蛋白 H3 精氨酸 2 上的二元精氨酸甲基化开关调节其与 WDR5 的相互作用。
Biochemistry. 2020 Oct 6;59(39):3696-3708. doi: 10.1021/acs.biochem.0c00035. Epub 2020 Mar 31.
5
PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease.PRMT5 调节 T 细胞干扰素反应,是急性移植物抗宿主病的靶点。
JCI Insight. 2020 Apr 23;5(8):131099. doi: 10.1172/jci.insight.131099.
6
LncRNA SNHG16 functions as an oncogene by sponging miR-200a-3p in pancreatic cancer.长链非编码RNA SNHG16在胰腺癌中通过吸附miR-200a-3p发挥癌基因作用。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):1718-1724. doi: 10.26355/eurrev_202002_20347.
7
Protein arginine methyltransferase 5 promotes cholesterol biosynthesis-mediated Th17 responses and autoimmunity.精氨酸甲基转移酶 5 促进胆固醇生物合成介导的 Th17 反应和自身免疫。
J Clin Invest. 2020 Apr 1;130(4):1683-1698. doi: 10.1172/JCI131254.
8
PRMT5-mediated histone arginine methylation antagonizes transcriptional repression by polycomb complex PRC2.PRMT5 介导的组蛋白精氨酸甲基化拮抗多梳复合物 PRC2 的转录抑制。
Nucleic Acids Res. 2020 Apr 6;48(6):2956-2968. doi: 10.1093/nar/gkaa065.
9
Histone H2AK119 Mono-Ubiquitination Is Essential for Polycomb-Mediated Transcriptional Repression.组蛋白H2AK119单泛素化对于多梳蛋白介导的转录抑制至关重要。
Mol Cell. 2020 Feb 20;77(4):840-856.e5. doi: 10.1016/j.molcel.2019.11.021. Epub 2019 Dec 26.
10
Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma.蛋白质精氨酸甲基转移酶5抑制肿瘤抑制性微小RNA,这些微小RNA在侵袭性B细胞淋巴瘤中下调细胞周期蛋白D1和c-MYC的表达。
J Biol Chem. 2020 Jan 31;295(5):1165-1180. doi: 10.1074/jbc.RA119.008742. Epub 2019 Dec 10.